ACA vs SRPT · P/E 57, rev $2.88B vs rev $1.90B
Arcosa Inc (ACA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ACA and SRPT stock pages for the full models.
Not investment advice.